A PHASE I CLINICAL TRIAL OF EPO906 IN COMBINATION WITH OXALIPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Keefe, S. M. [1 ]
Avadhani, A. N. [1 ]
Flaherty, K. T. [1 ]
Redlinger, M. [1 ]
O'Dwyer, P. J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
    Charles J. Nock
    Joanna M. Brell
    Joseph A. Bokar
    Matthew M. Cooney
    Brenda Cooper
    Joseph Gibbons
    Smitha Krishnamurthi
    Sudhir Manda
    Panayiotis Savvides
    Scot C. Remick
    Percy Ivy
    Afshin Dowlati
    Investigational New Drugs, 2011, 29 : 126 - 130
  • [42] A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
    Nock, Charles J.
    Brell, Joanna M.
    Bokar, Joseph A.
    Cooney, Matthew M.
    Cooper, Brenda
    Gibbons, Joseph
    Krishnamurthi, Smitha
    Manda, Sudhir
    Savvides, Panayiotis
    Remick, Scot C.
    Ivy, Percy
    Dowlati, Afshin
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (01) : 126 - 130
  • [43] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [44] Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Baldini, C.
    Danlos, F-X.
    Varga, A.
    Halse, H.
    Mouraud, S.
    Cassard, L.
    Bredel, D.
    Escriou, G.
    Parpaleix, A.
    Rafie, S.
    Abbassi, A. E.
    Laghouati, S.
    Farhane, S.
    Tselikas, L.
    Texier, M.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Massard, C.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S842 - S843
  • [45] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Piatek, Caroline I.
    Raja, Grace L.
    Ji, Lingyun
    Gitlitz, Barbara Jennifer
    Dorff, Tanya B.
    Quinn, David I.
    Hu, James
    El-Khoueiry, Anthony B.
    Pham, Huyen Q.
    Roman, Lynda
    Garcia, Agustin A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1227 - 1234
  • [46] Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors
    Caroline I. Piatek
    Grace L. Raja
    Lingyun Ji
    Barbara Jennifer Gitlitz
    Tanya B. Dorff
    David I. Quinn
    James Hu
    Anthony B. El-Khoueiry
    Huyen Q. Pham
    Lynda Roman
    Agustin A. Garcia
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1227 - 1234
  • [47] Capecitabine (Xeloda®) in combination with oxaliplatin:: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors
    Díaz-Rubio, E
    Evans, TRJ
    Tabernero, J
    Cassidy, J
    Sastre, J
    Eatock, M
    Bisset, D
    Regueiro, P
    Baselga, J
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 558 - 565
  • [48] Updated results of a phase I trial of Tomudex® (T) in combination with oxaliplatin (L-OHP) in advanced solid tumors:: A promising and active combination
    Ducreux, M
    Fizazi, K
    Daniel, C
    Ruffle, P
    Kabouche, A
    Fandi, A
    Smith, M
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [49] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Naing, Aung
    Falchook, Gerald
    Fu, Siqing
    Wheler, Jennifer J.
    Piha-Paul, Sarina
    Tsimberidou, Apostolia-Maria
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 575 - 581
12345